Category: Biologics
Biologics market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Biosimilars and Related Biologics
The 2025-2030 World Outlook for Biosimilars and Related Biologics This study covers the world outlook for biosimilars and related biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Regenerative Bone and Joint Medicines
The 2025-2030 World Outlook for Regenerative Bone and Joint Medicines This study covers the world outlook for regenerative bone and joint medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Wound Biologics
The 2025-2030 World Outlook for Wound Biologics This study covers the world outlook for wound biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Third Party Logistics
The 2025-2030 World Outlook for Biopharmaceutical Third Party Logistics This study covers the world outlook for biopharmaceutical third party logistics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Biologic Therapeutic Drugs
The 2025-2030 World Outlook for Biologic Therapeutic Drugs This study covers the world outlook for biologic therapeutic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Therapeutic-Protein Biological Drugs
The 2025-2030 World Outlook for Therapeutic-Protein Biological Drugs This study covers the world outlook for therapeutic-protein biological drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibody Biopharmaceuticals
The 2025-2030 World Outlook for Monoclonal Antibody Biopharmaceuticals This study covers the world outlook for monoclonal antibody biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Interleukin Inhibitors
The 2025-2030 World Outlook for Interleukin Inhibitors This study covers the world outlook for interleukin inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Anti-Inflammatory Biologics
The 2025-2030 World Outlook for Anti-Inflammatory Biologics This study covers the world outlook for anti-inflammatory biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Biological Safety Testing
The 2025-2030 World Outlook for Biological Safety Testing This study covers the world outlook for biological safety testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Logistics
The 2025-2030 World Outlook for Biopharmaceutical Logistics This study covers the world outlook for biopharmaceutical logistics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Biopharmaceuticals
The 2025-2030 World Outlook for Biopharmaceuticals This study covers the world outlook for biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Biologic Imaging Reagents
The 2025-2030 World Outlook for Biologic Imaging Reagents This study covers the world outlook for biologic imaging reagents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Wound Care Biologics
The 2025-2030 World Outlook for Wound Care Biologics This study covers the world outlook for wound care biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Viscosupplementation Orthobiologics
The 2025-2030 World Outlook for Viscosupplementation Orthobiologics This study covers the world outlook for viscosupplementation orthobiologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Spine Biologics
The 2025-2030 World Outlook for Spine Biologics This study covers the world outlook for spine biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Biological Drugs
The 2025-2030 World Outlook for Biological Drugs This study covers the world outlook for biological drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Biologic and Medical Imaging Reagents
The 2025-2030 World Outlook for Biologic and Medical Imaging Reagents This study covers the world outlook for biologic and medical imaging reagents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Single-Use Technology in the Biopharmaceuticals
The 2025-2030 World Outlook for Single-Use Technology in the Biopharmaceuticals This study covers the world outlook for single-use technology in the biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Peptide Synthesis
The 2025-2030 World Outlook for Peptide Synthesis This study covers the world outlook for peptide synthesis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Orphan Biologic Drugs
The 2025-2030 World Outlook for Orphan Biologic Drugs This study covers the world outlook for orphan biologic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Biologicals
The 2025-2030 World Outlook for Biologicals This study covers the world outlook for biologicals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics Drugs
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics Drugs This study covers the world outlook for biosimilars and follow-on biologics drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Biologics Safety Testing Instruments
The 2025-2030 World Outlook for Biologics Safety Testing Instruments This study covers the world outlook for biologics safety testing instruments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Biological Safety Testing Products and Services
The 2025-2030 World Outlook for Biological Safety Testing Products and Services This study covers the world outlook for biological safety testing products and services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
Research Assistance
